Brucellosis in central Anatolia: evaluation of complications and relapse
暂无分享,去创建一个
[1] E. J. Young,et al. Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations , 2007, PLoS medicine.
[2] M. Bosilkovski,et al. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. , 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[3] J. Solera,et al. A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] M. R. Roushan,et al. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. , 2004, Swiss medical weekly.
[5] N. Tulek,et al. Unusual Clinical Presentations of Brucellosis , 2004, Scandinavian journal of infectious diseases.
[6] J. D. Colmenero,et al. Complications Associated with Brucella melitensis Infection: A Study of 530 Cases , 1996, Medicine.
[7] J. Ariza,et al. Characteristics of and risk factors for relapse of brucellosis in humans. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] S. Unal,et al. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin , 1993, Antimicrobial Agents and Chemotherapy.